KRAS and adenomyosis: In the endometrium, endometriosis, adenomyosis and leiomyoma, the most frequently and activating-type genetic alterations were detected in PIC3CA, KRAS, PPP2RIA and MED12, whereas ARIDIA mutations lead to a loss of function [128,129,130].